Bicycle Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Bicycle Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Bicycle Therapeutics Plc - ADR
Rating: 1.52425
Author: Trendlyne DVM scores

about

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

6.95 -0.27 (-3.74%)

49.01% Fall from 52W High

151.8K

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

20.0 / 100

Technically Neutral

41.0 / 100

1Yr Price target upside is 209%

10 analysts

Bicycle Therapeutics PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bicycle Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural ge...

49.01% Fall from 52W High

SWOT Analysis

Bicycle Therapeutics PLC (ADR) Live Price Chart